Analyzers, Point-of-Care, Whole Blood, Multianalyte, Cardiovascular Marker

Definition : Multianalyte point-of-care analyzers designed to detect and determine the concentration of analytes (cardiac markers) in whole blood appropriate for rapid assessment of acute cardiovascular diseases such as acute coronary syndrome and/or myocardial infarction. Key cardiac markers include troponin I or T, myoglobin, creatine kinase MB, D-dimer and N-terminal pro-natriuretic peptide (NT-proBNP). These analyzers are typically portable electronic units with a display and appropriate software; tests are performed using disposable reagent strips and/or cartridges. Cardiovascular multianalyte point-of-care analyzers are intended for use in emergency rooms and doctors' offices; they may also be used to aid in the assessment and management of other cardiovascular diseases such as congestive heart failure, deep vein thrombosis, and pulmonary embolism.

Entry Terms : "Cardiac Marker Analyzers, Whole Blood, Point-of-Care" , "Cardiovascular Marker Whole Blood Point-of-Care Analyzers" , "Cardiovascular Disease Whole Blood Point-of-Care Analyzers" , "Congestive Heart Failure Analyzers" , "N-Terminal-proBNP Analyzers" , "Thrombosis Marker D-Dimer Analyzers" , "Myocardial Infarction Analyzers" , "D Myoglobin Analyzers" , "Troponin T Analyzers"

UMDC code : 23482

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

Immucor Inc

Company Type: Parent

Immucor, Inc. plays a vital role in making blood transfusions safe. We sell a complete line of automated instrument-reagents systems that detect and identify certain properties of blood prior to transfusion. Our strategy is to drive automation in the blood bank.

Kamiya Biomedical Co

Company Type: Parent

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California, with the purpose of supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.

Nexus Dx

Company Type: Parent

Nexus Dx is a global provider of Near Patient Testing systems and advanced diagnostic solutions. The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most.

1-4 of 4 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone